Korea United Pharm Inc
KRX:033270
Korea United Pharm Inc
KRX:033270
Price:
20 750
KRW
-0.48%
Market Cap:
305.3B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Korea United Pharm Inc
20750
-100 (-0.48%)
| 52 Week Range |
20 600
27 550
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Korea United Pharm Inc
Income Statement
Earnings Waterfall
Korea United Pharm Inc
Korea United Pharm Inc
|
Revenue
|
285.8B
KRW
|
|
Cost of Revenue
|
-122.7B
KRW
|
|
Gross Profit
|
163.1B
KRW
|
|
Operating Expenses
|
-107.3B
KRW
|
|
Operating Income
|
55.8B
KRW
|
|
Other Expenses
|
-23.6B
KRW
|
|
Net Income
|
32.2B
KRW
|
Income Statement
Korea United Pharm Inc
Korea United Pharm Inc
Currency: KRW
| Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
143 567
N/A
|
149 478
+4%
|
155 190
+4%
|
157 744
+2%
|
159 140
+1%
|
161 437
+1%
|
162 046
+0%
|
165 307
+2%
|
167 874
+2%
|
172 648
+3%
|
176 905
+2%
|
179 972
+2%
|
187 720
+4%
|
194 422
+4%
|
197 023
+1%
|
200 689
+2%
|
202 728
+1%
|
202 227
0%
|
211 936
+5%
|
216 434
+2%
|
219 230
+1%
|
222 997
+2%
|
221 311
-1%
|
219 114
-1%
|
215 513
-2%
|
215 785
+0%
|
215 950
+0%
|
212 949
-1%
|
219 235
+3%
|
221 400
+1%
|
221 040
0%
|
234 519
+6%
|
241 651
+3%
|
250 277
+4%
|
262 522
+5%
|
267 729
+2%
|
271 949
+2%
|
276 805
+2%
|
278 943
+1%
|
283 318
+2%
|
285 776
+1%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(68 333)
|
(70 828)
|
(72 097)
|
(71 862)
|
(72 165)
|
(74 386)
|
(74 527)
|
(75 486)
|
(76 478)
|
(77 569)
|
(80 075)
|
(81 966)
|
(84 834)
|
(85 116)
|
(85 162)
|
(85 514)
|
(87 190)
|
(88 243)
|
(86 459)
|
(88 008)
|
(88 097)
|
(89 907)
|
(92 723)
|
(90 838)
|
(89 283)
|
(88 990)
|
(90 758)
|
(91 911)
|
(95 636)
|
(97 747)
|
(98 380)
|
(104 767)
|
(106 661)
|
(109 968)
|
(117 234)
|
(118 426)
|
(118 174)
|
(119 234)
|
(119 966)
|
(121 122)
|
(122 691)
|
|
| Gross Profit |
75 237
N/A
|
78 652
+5%
|
83 092
+6%
|
85 883
+3%
|
86 976
+1%
|
87 052
+0%
|
87 519
+1%
|
89 823
+3%
|
91 397
+2%
|
95 080
+4%
|
96 830
+2%
|
98 006
+1%
|
102 886
+5%
|
109 306
+6%
|
111 862
+2%
|
115 175
+3%
|
115 538
+0%
|
113 984
-1%
|
125 477
+10%
|
128 426
+2%
|
131 133
+2%
|
133 089
+1%
|
128 588
-3%
|
128 276
0%
|
126 230
-2%
|
126 796
+0%
|
125 192
-1%
|
121 037
-3%
|
123 598
+2%
|
123 652
+0%
|
122 660
-1%
|
129 752
+6%
|
134 990
+4%
|
140 310
+4%
|
145 288
+4%
|
149 303
+3%
|
153 775
+3%
|
157 572
+2%
|
158 977
+1%
|
162 195
+2%
|
163 085
+1%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(59 473)
|
(60 335)
|
(61 106)
|
(62 350)
|
(62 482)
|
(64 067)
|
(64 604)
|
(68 713)
|
(69 779)
|
(70 055)
|
(69 712)
|
(71 856)
|
(75 247)
|
(76 402)
|
(80 145)
|
(80 877)
|
(80 087)
|
(81 376)
|
(87 726)
|
(91 891)
|
(95 765)
|
(98 003)
|
(94 108)
|
(92 851)
|
(88 455)
|
(86 463)
|
(85 066)
|
(82 538)
|
(85 318)
|
(87 546)
|
(89 434)
|
(93 069)
|
(95 746)
|
(97 134)
|
(97 074)
|
(99 707)
|
(99 906)
|
(100 220)
|
(104 028)
|
(102 872)
|
(107 270)
|
|
| Selling, General & Administrative |
(54 715)
|
(55 591)
|
(56 012)
|
(57 148)
|
(57 340)
|
(59 025)
|
(59 992)
|
(61 117)
|
(63 206)
|
(64 355)
|
(64 998)
|
(66 866)
|
(70 141)
|
(71 202)
|
(74 477)
|
(74 696)
|
(73 725)
|
(75 098)
|
(74 207)
|
(75 849)
|
(76 977)
|
(77 419)
|
(78 750)
|
(77 949)
|
(74 622)
|
(72 162)
|
(71 228)
|
(68 580)
|
(70 579)
|
(72 807)
|
(74 228)
|
(77 210)
|
(79 590)
|
(80 807)
|
(80 067)
|
(82 522)
|
(83 023)
|
(82 986)
|
(85 341)
|
(84 722)
|
(88 177)
|
|
| Research & Development |
(3 561)
|
(3 587)
|
(3 989)
|
(4 034)
|
(4 175)
|
(4 154)
|
(3 803)
|
(3 846)
|
(3 799)
|
(3 863)
|
(4 005)
|
(4 275)
|
(4 376)
|
(4 470)
|
(4 900)
|
(5 063)
|
(5 166)
|
(5 265)
|
(12 442)
|
(14 820)
|
(17 522)
|
(19 372)
|
(14 099)
|
(13 637)
|
(12 437)
|
(12 808)
|
(12 269)
|
(12 331)
|
(13 211)
|
(13 278)
|
(13 792)
|
(14 467)
|
(14 762)
|
(14 878)
|
(15 536)
|
(15 716)
|
(15 418)
|
(15 821)
|
(17 304)
|
(16 739)
|
(17 695)
|
|
| Depreciation & Amortization |
(1 201)
|
(1 159)
|
(1 105)
|
(1 039)
|
(966)
|
(887)
|
(809)
|
(751)
|
(712)
|
(712)
|
(709)
|
(713)
|
(728)
|
(727)
|
(768)
|
(847)
|
(927)
|
(1 011)
|
(1 078)
|
(1 131)
|
(1 175)
|
(1 212)
|
(1 259)
|
(1 265)
|
(1 396)
|
(1 493)
|
(1 569)
|
(1 626)
|
(1 527)
|
(1 459)
|
(1 415)
|
(1 392)
|
(1 395)
|
(1 449)
|
(1 472)
|
(1 469)
|
(1 465)
|
(1 414)
|
(1 383)
|
(1 411)
|
(1 398)
|
|
| Other Operating Expenses |
4
|
0
|
0
|
(129)
|
0
|
0
|
0
|
(2 999)
|
(2 062)
|
(1 125)
|
0
|
0
|
0
|
(3)
|
0
|
(271)
|
(269)
|
0
|
0
|
(91)
|
(91)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
15 761
N/A
|
18 315
+16%
|
21 987
+20%
|
23 532
+7%
|
24 493
+4%
|
22 984
-6%
|
22 915
0%
|
21 108
-8%
|
21 617
+2%
|
25 025
+16%
|
27 118
+8%
|
26 151
-4%
|
27 640
+6%
|
32 904
+19%
|
31 717
-4%
|
34 299
+8%
|
35 452
+3%
|
32 609
-8%
|
37 751
+16%
|
36 535
-3%
|
35 368
-3%
|
35 086
-1%
|
34 479
-2%
|
35 424
+3%
|
37 774
+7%
|
40 332
+7%
|
40 126
-1%
|
38 500
-4%
|
38 281
-1%
|
36 106
-6%
|
33 225
-8%
|
36 683
+10%
|
39 244
+7%
|
43 176
+10%
|
48 213
+12%
|
49 596
+3%
|
53 869
+9%
|
57 352
+6%
|
54 950
-4%
|
59 323
+8%
|
55 814
-6%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(821)
|
329
|
224
|
654
|
2 049
|
2 863
|
2 608
|
2 073
|
1 545
|
(526)
|
1 537
|
23
|
535
|
1 897
|
(2 771)
|
(905)
|
654
|
159
|
3 439
|
4 622
|
3 788
|
7 105
|
4 083
|
7 453
|
4 988
|
153
|
(3 381)
|
(4 556)
|
(3 892)
|
2 546
|
8 655
|
7 486
|
15 804
|
25 478
|
9 383
|
12 052
|
6 207
|
(3 239)
|
8 670
|
10 728
|
12 106
|
|
| Non-Reccuring Items |
0
|
0
|
(129)
|
0
|
(1 066)
|
(2 003)
|
(2 062)
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
(267)
|
0
|
0
|
(358)
|
(91)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(648)
|
(667)
|
(24 816)
|
|
| Gain/Loss on Disposition of Assets |
32
|
13
|
(33)
|
(78)
|
(50)
|
0
|
335
|
299
|
377
|
180
|
(1 688)
|
(1 544)
|
(2 058)
|
(1 893)
|
(334)
|
(492)
|
(87)
|
(62)
|
(74)
|
0
|
(8)
|
(1)
|
(105)
|
(148)
|
(147)
|
(147)
|
(34)
|
98
|
38
|
12
|
91
|
0
|
249
|
317
|
237
|
238
|
50
|
9
|
2
|
1
|
(562)
|
|
| Total Other Income |
1 016
|
1 512
|
732
|
235
|
798
|
1 774
|
1 045
|
2 698
|
2 480
|
781
|
489
|
(272)
|
610
|
1 445
|
172
|
133
|
(888)
|
(1 322)
|
(1 086)
|
(288)
|
(346)
|
(800)
|
76
|
(1 090)
|
(916)
|
(28)
|
(1 061)
|
(995)
|
(1 057)
|
(2 019)
|
(2 488)
|
(2 166)
|
(2 401)
|
(1 698)
|
(4 408)
|
(5 095)
|
(4 531)
|
(5 167)
|
(2 890)
|
(2 744)
|
(2 790)
|
|
| Pre-Tax Income |
15 986
N/A
|
20 168
+26%
|
22 780
+13%
|
24 341
+7%
|
26 223
+8%
|
25 618
-2%
|
24 841
-3%
|
26 178
+5%
|
26 020
-1%
|
25 462
-2%
|
27 457
+8%
|
24 360
-11%
|
26 726
+10%
|
34 353
+29%
|
28 517
-17%
|
33 035
+16%
|
35 132
+6%
|
31 027
-12%
|
39 939
+29%
|
40 869
+2%
|
38 803
-5%
|
41 392
+7%
|
38 534
-7%
|
41 641
+8%
|
41 699
+0%
|
40 311
-3%
|
35 650
-12%
|
33 047
-7%
|
33 370
+1%
|
36 645
+10%
|
39 483
+8%
|
42 002
+6%
|
52 897
+26%
|
67 273
+27%
|
53 425
-21%
|
56 790
+6%
|
55 595
-2%
|
48 956
-12%
|
60 084
+23%
|
66 641
+11%
|
39 753
-40%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(2 491)
|
(3 584)
|
(4 300)
|
(4 925)
|
(5 769)
|
(5 548)
|
(3 120)
|
(3 653)
|
(5 883)
|
(5 861)
|
(7 943)
|
(6 976)
|
(4 370)
|
(5 723)
|
(654)
|
(1 559)
|
(2 419)
|
(1 697)
|
(8 266)
|
(8 425)
|
(7 756)
|
(8 673)
|
(7 618)
|
(8 342)
|
(10 564)
|
(10 246)
|
(9 037)
|
(8 931)
|
(7 030)
|
(7 400)
|
(10 834)
|
(11 056)
|
(13 820)
|
(15 142)
|
(8 150)
|
(8 518)
|
(7 688)
|
(8 056)
|
(11 822)
|
(13 655)
|
(7 512)
|
|
| Income from Continuing Operations |
13 495
|
16 584
|
18 479
|
19 416
|
20 454
|
20 069
|
21 721
|
22 525
|
20 137
|
19 602
|
19 514
|
17 384
|
22 356
|
28 630
|
27 864
|
31 476
|
32 713
|
29 330
|
31 672
|
32 445
|
31 048
|
32 720
|
30 916
|
33 298
|
31 134
|
30 064
|
26 613
|
24 117
|
26 341
|
29 246
|
28 649
|
30 946
|
39 077
|
52 131
|
45 275
|
48 272
|
47 907
|
40 899
|
48 262
|
52 985
|
32 241
|
|
| Income to Minority Interest |
(44)
|
(37)
|
(104)
|
(166)
|
(56)
|
(49)
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
13 399
N/A
|
16 547
+23%
|
18 375
+11%
|
19 251
+5%
|
20 399
+6%
|
20 021
-2%
|
21 725
+9%
|
22 529
+4%
|
20 137
-11%
|
19 600
-3%
|
19 514
0%
|
17 384
-11%
|
22 356
+29%
|
28 630
+28%
|
27 864
-3%
|
31 476
+13%
|
32 713
+4%
|
29 330
-10%
|
31 672
+8%
|
32 445
+2%
|
31 048
-4%
|
32 720
+5%
|
30 916
-6%
|
33 298
+8%
|
31 134
-6%
|
30 064
-3%
|
26 613
-11%
|
24 117
-9%
|
26 341
+9%
|
29 246
+11%
|
28 649
-2%
|
30 946
+8%
|
39 077
+26%
|
52 131
+33%
|
45 275
-13%
|
48 272
+7%
|
47 907
-1%
|
40 899
-15%
|
48 262
+18%
|
52 985
+10%
|
32 241
-39%
|
|
| EPS (Diluted) |
837.43
N/A
|
1 034.18
+23%
|
1 148.43
+11%
|
1 203.18
+5%
|
1 274.93
+6%
|
1 251.31
-2%
|
1 357.81
+9%
|
1 501.93
+11%
|
1 342.46
-11%
|
1 306.66
-3%
|
1 300.93
0%
|
1 158.93
-11%
|
1 490.4
+29%
|
1 908.66
+28%
|
1 857.6
-3%
|
2 098.4
+13%
|
2 180.86
+4%
|
1 955.33
-10%
|
2 111.46
+8%
|
2 163
+2%
|
2 069.86
-4%
|
2 181.33
+5%
|
2 061.06
-6%
|
2 219.86
+8%
|
2 075.6
-6%
|
2 004.26
-3%
|
1 774.2
-11%
|
1 607.8
-9%
|
1 773.32
+10%
|
1 969.03
+11%
|
1 917.77
-3%
|
2 070.95
+8%
|
2 632.62
+27%
|
3 536.26
+34%
|
3 038.18
-14%
|
3 104.41
+2%
|
3 276.31
+6%
|
2 797.04
-15%
|
3 277.48
+17%
|
3 613.25
+10%
|
2 191.56
-39%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
